Delcath Systems Files 8-K: Financial and Operational Updates
Ticker: DCTH · Form: 8-K · Filed: Oct 17, 2024 · CIK: 872912
Sentiment: neutral
Topics: 8-k, financial-condition, operations
TL;DR
DELCATH filed an 8-K on Oct 17, 2024, with financial and operational updates. Keep an eye on this.
AI Summary
On October 17, 2024, Delcath Systems, Inc. filed an 8-K report detailing significant financial and operational updates. The filing indicates a shift in the company's financial condition and potentially other material events impacting its business operations.
Why It Matters
This filing provides crucial information for investors and stakeholders regarding Delcath Systems' current financial standing and any recent material events that could affect the company's future performance.
Risk Assessment
Risk Level: medium — 8-K filings often contain material information that can lead to significant stock price movements, necessitating careful review by investors.
Key Players & Entities
- DELCATH SYSTEMS, INC. (company) — Registrant
- October 17, 2024 (date) — Date of Report
- 001-16133 (other) — Commission File Number
- 566 Queensbury Avenue, Queensbury, NY 12804 (address) — Principal Executive Offices
FAQ
What specific financial information is being updated in this 8-K filing?
The filing indicates updates related to 'Results of Operations and Financial Condition' but does not provide specific dollar amounts or detailed financial statements within the provided text.
What are the 'Other Events' mentioned in the filing?
The filing lists 'Other Events' as an item information, but the specific nature of these events is not detailed in the provided text.
When was this 8-K report filed?
The report was filed on October 17, 2024.
What is Delcath Systems, Inc.'s primary business classification?
Delcath Systems, Inc. is classified under 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]'.
Where are Delcath Systems, Inc.'s principal executive offices located?
The principal executive offices are located at 566 Queensbury Avenue, Queensbury, NY 12804.
Filing Stats: 727 words · 3 min read · ~2 pages · Grade level 11.5 · Accepted 2024-10-17 08:53:59
Key Financial Figures
- $11.2 m — elcath expects revenue of approximately $11.2 million, of which $10.0 million is revenu
- $10.0 million — f approximately $11.2 million, of which $10.0 million is revenue generated from the commercia
- $6.00 — f common stock at an effective price of $6.00 per share of common stock for an aggreg
- $25 million — e exercise price of up to approximately $25 million. Delcath has not completed preparatio
Filing Documents
- d837829d8k.htm (8-K) — 26KB
- d837829dex991.htm (EX-99.1) — 10KB
- 0001193125-24-238564.txt ( ) — 157KB
- dcth-20241017.xsd (EX-101.SCH) — 3KB
- dcth-20241017_lab.xml (EX-101.LAB) — 17KB
- dcth-20241017_pre.xml (EX-101.PRE) — 11KB
- d837829d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated October 17, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. DELCATH SYSTEMS, INC. Date: October 17, 2024 By: /s/ Gerard Michel Name: Gerard Michel Title: Chief Executive Officer